| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.56B | +31.4% |
| Cost of Revenue | $608.0M | +31.8% |
| Gross Profit | $955.4M | +31.1% |
| R&D Expense | $303.7M | +29.9% |
| SG&A Expense | $496.9M | +23.7% |
| Operating Income | $154.8M | +66.0% |
| Pre-tax Income | $155.0M | -21.1% |
| Income Tax | -$19.2M | -138.9% |
| Net Income | $174.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $598.5M | +69.2% |
| Short-term Investments | $644.1M | +10.7% |
| Inventory | $269.9M | +33.3% |
| Current Assets | $2.40B | +32.8% |
| Total Assets | $3.44B | +20.5% |
| Current Liabilities | $800.0M | +32.7% |
| Total Liabilities | $1.82B | +15.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $189.3M | -19.6% |
| Capital Expenditures | $59.6M | +6.9% |
| Investing Cash Flow | $12.5M | +101.5% |
| Financing Cash Flow | $41.3M | -93.1% |
| Free Cash Flow | $129.6M | -27.8% |
| +18.4% |
| EPS (Basic) | $2.35 | +13.5% |
| EPS (Diluted) | $2.31 | +13.8% |
| Stockholders' Equity |
| $1.61B |
| +27.1% |